AzTrials
AzTrials

LymphedemaNCT02475174

Manual Lymphatic Drainage in the Superior Member in Women in Post-surgery for Breast Cancer

A study testing Without upper limb elevation and Upper limb elevation to 30º in people with Lymphedema, run by University of Sao Paulo.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluate the effect of Manual Lymphatic Drainage (MLD) massage in arterial and venous circulation of the upper limb ipsilateral of women submitted after axillary lymphadenectomy breast cancer. Read more about this study

Who is it for?
Ages 40 to 60 years, women only
Conditions the study is for
Lymphedema
What is being tested?
Without upper limb elevation and Upper limb elevation to 30º
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
Jun 2015to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women with axillary lymphadenectomy surgery
  • Lymphedema
  • Aged 40-60 years.

Who cannot join

  • Women with muscle-tendon injury and / or joint injuries member
  • Skin disorders
  • circulatory diseases.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Blood Circulation Assessment of the Superior Member in Women in Post-surgery for Breast Cancer Submitted to the Manual Lymphatic Drainage

Evaluate the effect of Manual Lymphatic Drainage (MLD) massage in arterial and venous circulation of the upper limb ipsilateral of women submitted after axillary lymphadenectomy breast cancer.

Read the detailed description

The aim of the study is to evaluate the effect of Manual Lymphatic Drainage (MLD) massage in arterial and venous circulation of the upper limb ipsilateral of women submitted after axillary lymphadenectomy breast cancer. Will be evaluated 30 volunteers aged between 40 and 60 years, divided into 2 equal groups, submitted at MLD: Group 1 - volunteers who underwent surgery for breast cancer that have lymphedema, subject to manual lymphatic drainage without upper limb elevation; Group 2 - volunteers who underwent surgery for breast cancer that have lymphedema, subject to manual lymphatic drainage with the upper limb elevation to 30º. Data will be collected by ultrasound Doppler in vein and brachial artery before, after MLD, immediately after, and 30 minutes after therapeutic treatment, with and without elevation of 30°, cross over delimitation, being made a therapy session for therapeutic use with and without elevation, with interval period (washout) for seven days. The order of treatment protocols will be randomized by simple raffle for each volunteer. The data within and between groups will be evaluated by a statistical test t student or ANOVA. Otherwise it will be used Kruskal-Wallis followed test by Dunn. Data processing will be performed by software and fixed the critical level of 5% (p<0,05).

Conditions
Lymphedema
Being tested
Without upper limb elevation, Upper limb elevation to 30º
Medical subject headings
Lymphedema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Without upper limb elevationOther

    Lymphatic drainage without elevation of the upper limb.

  • Upper limb elevation to 30ºOther

    Lymphatic drainage with elevation of the upper limb to 30º.

Study groups in NCT02475174
Study groupRoleWhat they receive
Without upper limb elevationExperimentalManual lymphatic drainage will be held with the voluntary supine without upper limb elevation.
Receives: Other: Without upper limb elevation
Upper limb elevation to 30ºExperimentalManual lymphatic drainage will be held with the voluntary supine with the upper limb elevation to 30º.
Receives: Other: Upper limb elevation to 30º

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood flow velocity (Flow velocity in brachial artery and vein)

    Flow velocity in brachial and artery vein

    Measured: one day

Secondary outcomes (1)
  1. Volume upper limbs

    Volume upper limbs

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2015 (estimated)
  2. Study startJun 2015
  3. Primary completionJun 2015
  4. Study completionMar 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02475174
Sponsor's protocol ID
HCRP nº 13408/2013
Status last verified
Jun 2015
First submitted
10 Jun 2015
Last updated
18 Jun 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Without upper limb elevation and Upper limb elevation to 30º in people with Lymphedema, run by University of Sao Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Elaine Guirro ((16)3315-0215, ecguirro@fmrp.usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood flow velocity (Flow velocity in brachial artery and vein) (time frame: one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2015; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in